? This grant proposal requests the funds necessary to add the School of Dentistry's General and Oral Health Center (GOHC) to the GCRC of the School of Medicine of the UNC at Chapel Hill. Currently, there are three principle areas of joint collaboration and utilization that bring the investigators from the GCRC and the Dental School together to propose that the GOHC become an integrated new component of the GCRC. The first is the existing analytical capacity in the areas of inflammatory molecules and hormones that the Center for Oral and Systemic Diseases (COSD) Laboratory facilities can provide to the GCRC investigators. This phase of integration has been further unified with the recent appointment of Dr. Steven Offenbacher as the GCRC BioAnalytic Core (BAC) Laboratory Director and the offering of new services to GCRC investigators, as part of the newly funded cycle of the GCRC. The second interaction deals with the on-going utilization of the GCRC hospital inpatient clinical research facilities by COSD faculty. The third major area of collaboration involves the joint research projects that involve the collection of medical and oral data and samples on patients by both medical and dental GCRC investigators. ? ? This application contains a summary of the clinical research that has been carried out in the GOHC and then presents the proposed research activities, the plan for integration of the GOHC into the GCRC, and the benefits to both groups. They also have emphasized the role played by the GOHC in the education and training for current and future clinical investigators. ? ?

Agency
National Institute of Health (NIH)
Institute
National Center for Research Resources (NCRR)
Type
General Clinical Research Centers Program (M01)
Project #
3M01RR000046-43S1
Application #
6677675
Study Section
National Center for Research Resources Initial Review Group (RIRG)
Program Officer
Wilde, David B
Project Start
1974-10-01
Project End
2007-11-30
Budget Start
2003-05-22
Budget End
2003-11-30
Support Year
43
Fiscal Year
2003
Total Cost
$260,472
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Venuto, Charles S; Lim, Jihoon; Messing, Susan et al. (2018) Inflammation investigated as a source of pharmacokinetic variability of atazanavir in AIDS Clinical Trials Group protocol A5224s. Antivir Ther 23:345-351
Malinen, Melina M; Kauttonen, Antti; Beaudoin, James J et al. (2018) Novel In Vitro Method Reveals Drugs that Inhibit Solute Transporter Alpha/Beta (OST?/?). Mol Pharm :
Li, Binglan; Verma, Shefali S; Veturi, Yogasudha C et al. (2018) Evaluation of PrediXcan for prioritizing GWAS associations and predicting gene expression. Pac Symp Biocomput 23:448-459
Hanly, John G; Li, Qiuju; Su, Li et al. (2018) Cerebrovascular Events in Systemic Lupus Erythematosus: Results From an International Inception Cohort Study. Arthritis Care Res (Hoboken) 70:1478-1487
Barber, Megan R W; Hanly, John G; Su, Li et al. (2018) Economic Evaluation of Lupus Nephritis in the Systemic Lupus International Collaborating Clinics Inception Cohort Using a Multistate Model Approach. Arthritis Care Res (Hoboken) 70:1294-1302
Rini, Christine; Vu, Maihan B; Lerner, Hannah et al. (2018) A qualitative study of patient and provider perspectives on using web-based pain coping skills training to treat persistent cancer pain. Palliat Support Care 16:155-169
Little, Jayne; Parker, Ben; Lunt, Mark et al. (2018) Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort. Rheumatology (Oxford) 57:677-687
Abdullah, Lubna H; Coakley, Raymond; Webster, Megan J et al. (2018) Mucin Production and Hydration Responses to Mucopurulent Materials in Normal versus Cystic Fibrosis Airway Epithelia. Am J Respir Crit Care Med 197:481-491
Martin, Maureen P; Naranbhai, Vivek; Shea, Patrick R et al. (2018) Killer cell immunoglobulin-like receptor 3DL1 variation modifies HLA-B*57 protection against HIV-1. J Clin Invest 128:1903-1912
Haas, David W; Bradford, Yuki; Verma, Anurag et al. (2018) Brain neurotransmitter transporter/receptor genomics and efavirenz central nervous system adverse events. Pharmacogenet Genomics 28:179-187

Showing the most recent 10 out of 782 publications